Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series. (Q48545881)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/22539243

Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series. (English)

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/22539243

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

toxic encephalopathy

1 reference

based on heuristic

inferred from title

author name string

Marc C Chamberlain

1

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/22539243

publication date

27 April 2012

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/22539243

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/22539243

109

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/22539243

1

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/22539243

143-148

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/22539243

https://scigraph.springernature.com/pub.10.1007/s11060-012-0880-x

0 references

Current Pharmacological Treatment Approaches to Central Nervous System Leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0880-X

21 January 2018

Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0880-X

21 January 2018

Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0880-X

21 January 2018

Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0880-X

21 January 2018

Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0880-X

21 January 2018

Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0880-X

21 January 2018

Non-AIDS-related lymphomatous meningitis: combined modality therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0880-X

21 January 2018

Combined-modality treatment of leptomeningeal gliomatosis

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0880-X

21 January 2018

Acute binocular blindness.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0880-X

21 January 2018

Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0880-X

21 January 2018

Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0880-X

21 January 2018

Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0880-X

21 January 2018

Toxicity of treatment for neoplastic meningitis

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0880-X

21 January 2018

Excessive spinal cord toxicity from intensive central nervous system-directed therapies

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0880-X

21 January 2018

The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539243

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539243

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leptomeningeal metastases due to melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539243

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539243

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539243

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myelomatous meningitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539243

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22539243

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-012-0880-X

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/22539243

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/22539243

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48545881&oldid=1588189130"